Opus Genetics, Inc.
Status: Publicly traded
Direct answer
Opus Genetics, Inc. is publicly traded on NASDAQ under the ticker IRD.
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation)....
Can you invest in Opus Genetics, Inc.?
Yes. Opus Genetics, Inc. is publicly traded on NASDAQ under the ticker IRD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Opus Genetics, Inc.
Detailed equity research is provided by MarketSnap.